Back
Grace Therapeutics Stock Price Chart
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
39
GRCE
Grace Therapeutics
Last Price:
3.08
Seasonality Move:
7.4%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade- The current trend is moderately bearish and GRCE is experiencing slight buying pressure.
Grace Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.21 | Sell |
| 20-day SMA: | 3.27 | Sell |
| 50-day SMA: | 2.92 | Buy |
| 200-day SMA: | 2.93 | Buy |
| 8-day EMA: | 3.19 | Sell |
| 20-day EMA: | 3.19 | Sell |
| 50-day EMA: | 3.03 | Buy |
| 200-day EMA: | 2.9 | Buy |
Grace Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 49.29 | Sell |
| Chaikin Money Flow: | -25 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.08 - 3.38) | Sell |
| Bollinger Bands (100): | (2.52 - 3.2) | Buy |
Grace Therapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Grace Therapeutics Stock
Is Grace Therapeutics Stock a Buy?
- Grace Therapeutics share price is 3.14 while GRCE 8-day simple moving average is 3.21, which is a Sell signal.
- The stock price of GRCE is 3.14 while Grace Therapeutics 20-day SMA is 3.27, which makes it a Sell.
- Grace Therapeutics 50-day simple moving average is 2.92 while GRCE share price is 3.14, making it a Buy technically.
- GRCE stock price is 3.14 and Grace Therapeutics 200-day simple moving average is 2.93, creating a Buy signal.
GRCE Technical Analysis vs Fundamental Analysis
Sell
39
Grace Therapeutics (GRCE)
is a Sell
Is Grace Therapeutics a Buy or a Sell?
-
Grace Therapeutics stock is rated a Sell
The current Grace Therapeutics [GRCE] share price is $3.14. The Score for GRCE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Grace Therapeutics Stock Info
Market Cap:
31.79M
Price in USD:
3.14
Share Volume:
11.97K
Grace Therapeutics 52-Week Range
52-Week High:
3.60
52-Week Low:
1.98
Sell
39
Grace Therapeutics (GRCE)
is a Sell
Grace Therapeutics Share Price Forecast
-
What is the Grace Therapeutics stock price today?
The Grace Therapeutics stock price is 3.14 USD today. -
Will GRCE stock go up or go down?
Grace Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Grace Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Grace Therapeutics is overvalued.
Is Grace Therapeutics Stock a Buy?
- Grace Therapeutics share price is 3.14 while GRCE 8-day exponential moving average is 3.19, which is a Sell signal.
- The stock price of GRCE is 3.14 while Grace Therapeutics 20-day EMA is 3.19, which makes it a Sell.
- Grace Therapeutics 50-day exponential moving average is 3.03 while GRCE share price is 3.14, making it a Buy technically.
- GRCE stock price is 3.14 and Grace Therapeutics 200-day simple moving average is 2.90, creating a Buy signal.
Fundamental Analysis of Grace Therapeutics
Is Grace Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.16 per share, and a decrease next year of $0.01 per share.
Technical Analysis of Grace Therapeutics
Should I short Grace Therapeutics stock?
- GRCE Moving Average Covergence Divergence (MACD) indicator is 0.05, suggesting Grace Therapeutics is a Buy
- Grace Therapeutics Relative Strength Index (RSI) is 49.29, which suggest Grace Therapeutics is oversold
- The Bollinger Bands (25) for Grace Therapeutics is (3.08 - 3.38), which suggest Grace Therapeutics is a Buy
- The Bollinger Bands (100) for Grace Therapeutics is (2.52 - 3.2), which suggest Grace Therapeutics is a Buy
* Grace Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.